These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series. Yip LW; Thong BY; Lim J; Tan AW; Wong HB; Handa S; Heng WJ Allergy; 2007 May; 62(5):527-31. PubMed ID: 17313402 [TBL] [Abstract][Full Text] [Related]
45. Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan. Chen KT; Twu SJ; Chang HJ; Lin RS Am J Public Health; 2003 Mar; 93(3):489-92. PubMed ID: 12604501 [TBL] [Abstract][Full Text] [Related]
46. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome. Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483 [TBL] [Abstract][Full Text] [Related]
47. Possible cefotaxime-induced Stevens-Johnson syndrome. Liberopoulos EN; Liamis GL; Elisaf MS Ann Pharmacother; 2003 Jun; 37(6):812-4. PubMed ID: 12773067 [TBL] [Abstract][Full Text] [Related]
48. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion. Brechue WF; Maren TH Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174 [TBL] [Abstract][Full Text] [Related]
49. Organic impotence associated with carbonic anhydrase inhibitor therapy for glaucoma. Epstein RJ; Allen RC; Lunde MW Ann Ophthalmol; 1987 Feb; 19(2):48-50. PubMed ID: 3566023 [TBL] [Abstract][Full Text] [Related]
50. The hypoxia-induced facilitation of augmented breaths is suppressed by the common effect of carbonic anhydrase inhibition. Bell HJ; Haouzi P Respir Physiol Neurobiol; 2010 May; 171(3):201-11. PubMed ID: 20382275 [TBL] [Abstract][Full Text] [Related]
52. Genetic association of IFN-γ +874T/A polymorphism in Mexican patients with drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Charli-Joseph Y; Lima G; Ramos-Bello D; Aguilar D; Orozco-Topete R; Llorente L Arch Dermatol Res; 2013 May; 305(4):353-7. PubMed ID: 23224615 [TBL] [Abstract][Full Text] [Related]
53. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study. Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410 [TBL] [Abstract][Full Text] [Related]
54. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Ueta M; Sotozono C; Inatomi T; Kojima K; Tashiro K; Hamuro J; Kinoshita S Br J Ophthalmol; 2007 Jul; 91(7):962-5. PubMed ID: 17314152 [TBL] [Abstract][Full Text] [Related]
55. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941 [TBL] [Abstract][Full Text] [Related]
56. Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan. Kunimi Y; Hirata Y; Aihara M; Yamane Y; Ikezawa Z Allergol Int; 2011 Dec; 60(4):525-32. PubMed ID: 22113160 [TBL] [Abstract][Full Text] [Related]
57. Cephalexin-induced Stevens-Johnson syndrome. Murray KM; Camp MS Ann Pharmacother; 1992 Oct; 26(10):1230-3. PubMed ID: 1421644 [TBL] [Abstract][Full Text] [Related]
58. Decreased macular thickness in nonproliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors. Chen JJ; Sohn EH; Folk JC; Mahajan VB; Kay CN; Boldt HC; Russell SR Retina; 2014 Jul; 34(7):1400-6. PubMed ID: 24451922 [TBL] [Abstract][Full Text] [Related]
59. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Carbonic Anhydrase Inhibitors: Epidemiology, Genetics, and Insights into Mechanisms. Trubiano JA; Ostrov DA; Phillips EJ J Allergy Clin Immunol Pract; 2019; 7(8):2854-2856. PubMed ID: 31706497 [No Abstract] [Full Text] [Related]
60. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa]. Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]